Catalog Home Page

Publications: Berry, Cassandra

Stats for Berry, Cassandra
Export as [feed] RSS
Group by: Publication Type | Year
Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
Number of items: 34.

2014

Rinaldi, C., Penhale, W.J., Stumbles, P.A., Tay, G. and Berry, C.M. (2014) Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. PLoS ONE, 9 (2).

2013

Le, X., Poinern, G.E.J., Ali, N., Berry, C.M. and Fawcett, D. (2013) Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials, 2013 . pp. 1-16.

2012

Poinern, G.E.J., Ali, N., Berry, C., Singh, P., Berchmans, S. and Fawcett, D. (2012) Biocompatibility of synthesised nano-porous anodic Aluminium oxide membranes for use as a cell culture substrate for Madin-Darby Canine Kidneys cells: A preliminary study. Journal of Tissue Science & Engineering, 3 (3).

Berry, C.M., Hertzog, P.J. and Mangan, N.E. (2012) Interferons as biomarkers and effectors: lessons learned from animal models. Biomarkers in Medicine, 6 (2). pp. 159-176.

James-Berry, C.M. (2012) Vaccine control of avian influenza H5N1 in poultry: Need for a positive marker. Journal of Vaccines & Vaccination, 04 (01). p. 168.

2011

Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C.M., Überla, K., Dittmer, U. and Wildner, O. (2011) Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology, 8 (1). p. 75.

2010

Chua, T-H, Leung, C.Y.H., Fang, H. E., Chow, Ch-K, Ma, S-K, Sia, S-F, Ng, I.H.Y., Fenwick, S.G., James, C.M., Chua, S.B., Chew, S.T., Kwang, J., Peiris, J.S.M. and Ellis, T.M. (2010) Evaluation of a subunit H5 vaccine and an inactivated H5N2 avian influenza marker vaccine in ducks challenged with Vietnamese H5N1 highly pathogenic avian influenza virus. Influenza Research and Treatment, 2010 . pp. 1-10.

James-Berry, C.M., Middleton, D., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2010) Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Veterinary Record, 167 (18). pp. 695-699.

2009

Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., James, C.M. and Dittmer, U. (2009) Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology, 39 (1). pp. 136-146.

Eade, J.A., Robertson, I.D. and James-Berry, C.M. (2009) Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction, 137 (6). pp. 913-922.

2008

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Vind, A.R., Fenwick, S.G. and Ellis, T.M. (2008) Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine, 26 (42). pp. 5345-5351.

James, C.M., Duffy, S., Pemberton, D., Armson, A. and Stumbles, P. (2008) Interferon subtype stimulation of dendritic cells: Key activators of anti-viral immunity. Cytokine, 43 (3). p. 309.

2007

James-Berry, C.M., Abdad, M.Y., Mansfield, J.P., Jacobsen, H.K., Vind, A.R., Stumbles, P.A. and Bartlett, E.J. (2007) Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine, 25 (10). pp. 1856-1867.

James, C.M., Lisciandro, J., Gerlach, N., Dittmer, U. and Stumbles, P.A. (2007) Interferon-alpha subtypes differentially enhance dendritic cell biology. In: International Society for Interferon and Cytokine Research, Interferon Anniversary Meeting, 16 - 19 September, Oxford, England

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine, 25 (31). pp. 5892-5901.

2006

Austin, B.A., James-Berry, C.M., Härle, P. and Carr, D.J.J. (2006) Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biological Procedures Online, 8 (1). pp. 55-62.

2005

Austin, B.A., James, C., Silverman, R.H. and Carr, D.J.J. (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. Journal of Immunology, 175 (2). pp. 1100-1106.

James, C.M., Bartlett, E.J., Mansfield, J.P. and Cull, V.S. (2005) Interferon subtype gene therapy for regulating cytomegalovirus disease. Methods in molecular medicine, 116 . pp. 207-219.

2004

Bartlett, E.J., Lenzo, J.C., Sivamoorthy, S., Mansfield, J.P., Cull, V.S. and James, C.M. (2004) Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunology and Cell Biology, 82 (2). pp. 119-126.

2003

Lenzo, J.C., Mansfield, J.P., Sivamoorthy, S., Cull, V.S. and James, C.M. (2003) Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cellular Immunology, 223 (1). pp. 77-86.

Carr, D.J.J., Al-khatib, K., James, C.M. and Silverman, R. (2003) Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. Journal of Neuroimmunology, 141 (1-2). pp. 40-46.

Bartlett, E.J., Cull, V.S., Mowe, E.N., Mansfield, J.P. and James, C.M. (2003) Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection. Biological Procedures Online, 5 (1). pp. 43-52.

2002

Lenzo, J.C., Fairweather, D., Cull, V., Shellam, G.R. and James, C.M. (2002) Characterisation of murine cytomegalovirus myocarditis: Cellular infiltration of the heart and virus persistence. Journal of Molecular and Cellular Cardiology, 34 (6). pp. 629-640.

Cull, V.S., Broomfield, S., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2002) Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Therapy, 9 (20). pp. 1369-1378.

Bartlett, E.J., Cull, V.S., Brekalo, N.L., Lenzo, J.C. and James, C.M. (2002) Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection. Immunology and Cell Biology, 80 (5). pp. 425-435.

Härle, P., Cull, V., Guo, L., Papin, J., Lawson, C. and Carr, D.J.J. (2002) Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Research, 56 (1). pp. 39-49.

Cull, V.S., Bartlett, E.J. and James, C.M. (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology, 106 (3). pp. 428-437.

2001

Lenzo, J.C. and Lawson, C.M. (2001) Cytomegalovirus-induced myocarditis - An animal model for understanding pathogenesis and therapy. International Antiviral News, 9 (11). pp. 166-169.

Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M. and Rose, N.R. (2001) From infection to autoimmunity. Journal of Autoimmunity, 16 (3). pp. 175-186.

Lenzo, J.C., Shellam, G.R. and Lawson, C.M. (2001) Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrobial agents and chemotherapy, 45 (5). pp. 1444-1449.

Lenzo, J.C., Fairweather, D., Shellam, G.R. and Lawson, C.M. (2001) Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cellular Immunology, 213 (1). pp. 52-61.

2000

Lawson, C.M. (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cellular and Molecular Life Sciences, 57 (4). pp. 552-560.

1999

Bosio, E., Beilharz, M.W., Watson, M.W. and Lawson, C.M. (1999) Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. Journal of Interferon & Cytokine Research, 19 (8). pp. 869-876.

Lawson, C.M. and Beilharz, M.W. (1999) Low-dose oral use of interferon inhibits virally induced myocarditis. Journal of Interferon & Cytokine Research, 19 (8). pp. 863-867.

This list was generated on Sat Oct 25 11:13:07 2014 IST.